ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

DTC Defence Therapeutics Inc

0.518
-0.01 (-1.89%)
31 Jul 2024 - Closed
Realtime Data
Share Name Share Symbol Market Type
Defence Therapeutics Inc TG:DTC Tradegate Ordinary Share
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.01 -1.89% 0.518 0.50 0.536 0.548 0.486 0.548 27,920 22:50:01

Domtar to issue US$400 million of notes

03/08/2005 12:24am

PR Newswire (US)


Defence Therapeutics (TG:DTC)
Historical Stock Chart


From Aug 2019 to Aug 2024

Click Here for more Defence Therapeutics Charts.
TICKER SYMBOL DTC (TSX, NYSE) MONTREAL, Aug. 2 /PRNewswire-FirstCall/ -- Domtar announced today that it has entered into a definitive agreement with a group of underwriters for the sale of an aggregate principal amount of US$400 million of its 7.125 % notes due 2015 pursuant to a public offering in the United States. The group of underwriters is led by J.P. Morgan Securities Inc. and Citigroup Global Markets Inc. as joint book-running managers. Domtar intends to use the gross proceeds from the sale of the notes to redeem its 8.75% notes due in August 2006 in an aggregate principal amount of US$150 million and the balance to repay a substantial portion of its unsecured revolving credit facility. This communication shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. This communication is not, and under no circumstances is it to be construed as, an advertisement or a public offering of these securities in Canada. A copy of the prospectus may be obtained from J.P. Morgan Securities Inc., 270 Park Avenue, 8th Floor, New York, New York 10017 (telephone: (212) 834-4533). DOMTAR IS THE THIRD LARGEST PRODUCER OF UNCOATED FREESHEET PAPER IN NORTH AMERICA. IT IS ALSO A LEADING MANUFACTURER OF BUSINESS PAPERS, COMMERCIAL PRINTING AND PUBLICATION PAPERS, AND TECHNICAL AND SPECIALTY PAPERS. DOMTAR MANAGES ACCORDING TO INTERNATIONALLY RECOGNIZED STANDARDS 18 MILLION ACRES OF FORESTLAND IN CANADA AND THE UNITED STATES, AND PRODUCES LUMBER AND OTHER WOOD PRODUCTS. DOMTAR HAS 10,000 EMPLOYEES ACROSS NORTH AMERICA. THE COMPANY ALSO HAS A 50% INVESTMENT INTEREST IN NORAMPAC INC., THE LARGEST CANADIAN PRODUCER OF CONTAINERBOARD. DATASOURCE: DOMTAR INC. CONTACT: Christian Tardif, Manager, Corporate and Financial Communications, (514) 848-5515, christian.tardif@domtar; SOURCE: Daniel Buron, Senior Vice President and Chief Financial Officer, (514) 848-5234, ; To request a free copy of this organization's annual report, please go to http://www.newswire.ca/ and click on reports@cnw.

Copyright

1 Year Defence Therapeutics Chart

1 Year Defence Therapeutics Chart

1 Month Defence Therapeutics Chart

1 Month Defence Therapeutics Chart

Your Recent History